Literature DB >> 20878436

Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.

Kenshi Sakayama1, Yoshifumi Sugawara, Teruki Kidani, Taketsugu Fujibuchi, Katsumi Kito, Nozomu Tanji, Atsushi Nakamura.   

Abstract

We report a rare case of polyostotic fibrous dysplasia on endocrine hyperfunction with elevated human growth hormone and normal serum level of prolactin. There were some differential points of gender, gigantism, endocrine function, and GNAS gene from McCune-Albright syndrome. Malignant transformation was suspected in the pelvic tumor from imaging because rapid growth of the tumor by imaging was observed; however, no malignant change occurred in this case.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878436     DOI: 10.1007/s10147-010-0127-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  27 in total

1.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Authors:  W F Schwindinger; C A Francomano; M A Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

Authors:  C Polychronakos; G Tsoukas; J R Ducharme; J Letarte; R Collu
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

3.  Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.

Authors:  Michael T Collins; Nicholas J Sarlis; Maria J Merino; Jason Monroe; Susan E Crawford; Jonathan A Krakoff; Lori C Guthrie; Sandra Bonat; Pamela G Robey; Andrew Shenker
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

4.  Polyostotic fibrous dysplasia with acromegaly.

Authors:  R I Harris
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

5.  McCune-Albright syndrome with gigantism and hyperprolactinemia.

Authors:  F Pacini; G Perri; P Bagnolesi; A Cilotti; A Pinchera
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

6.  Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.

Authors:  N Cremonini; E Graziano; V Chiarini; A Sforza; G A Zampa
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

Review 7.  Gs(alpha) mutations and imprinting defects in human disease.

Authors:  Lee S Weinstein; Min Chen; Jie Liu
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

8.  Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.

Authors:  L Cuttler; J A Jackson; M Saeed uz-Zafar; L L Levitsky; R C Mellinger; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

9.  Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.

Authors:  Serge Lumbroso; Françoise Paris; Charles Sultan
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

10.  The McCune-Albright syndrome: a lethal gene surviving by mosaicism.

Authors:  R Happle
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

View more
  1 in total

Review 1.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.